Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model

Critical Care Medicine

Volumn 30, Issue 3, 2002, Pages 637-643

  Tasaki, Osamu ^a   Mozingo, David W ^b   Dubick, Michael A ^a   Goodwin, Cleon W ^a   Yantis, Loudon D ^d   Pruitt Jr , Basil A ^c  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d NONE

Author keywords

Cast formation; Free radical; Heparin; Leukocyte; Lisofylline; Malondialdehyde; Multiple inert gas elimination technique; Ovine; Pulmonary dysfunction; Smoke inhalation injury

Indexed keywords

HEPARIN; LISOFYLLINE; MALONALDEHYDE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD GAS ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ENDOTRACHEAL TUBE; LUNG BURN; LUNG FUNCTION; LUNG INJURY; LUNG VENTILATION PERFUSION RATIO; NEBULIZER; NONHUMAN; PRIORITY JOURNAL; SHEEP; TREATMENT OUTCOME;

EID: 0036191603     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200203000-00024     Document Type: Article

References (38)

1. Effect of inhalation injury on fluid resuscitation requirements after thermal injury
2. Effect of graded increases in smoke inhalation injury on the early systemic response to a body burn
3. Pulmonary injury in burned patients
4. Heparin improves oxygenation and minimizes barotrauma after severe smoke inhalation in an ovine model
5. Effects of porcine heparin on oxygenation and pulmonary transvascular fluid flux after smoke inhalation in sheep
6. The effects of pentoxifylline on pulmonary function following smoke inhalation
7. Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol
8. CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo
9. Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock
10. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12 mediated Th1 differentiation: An effect of the novel anti-inflammatory drug lisofylline
11. Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion
12. Effects of Sulfo Lewis C on smoke inhalation injury in an ovine model
13. Clinical relevance of ventilation-perfusion inequality determined by inert gas elimination
14. The effects of inhaled nitric oxide on smoke inhalation injury in an ovine model
15. Lipid peroxides as the initiating factor of atherosclerosis
16. Myeloperoxidase as a biomarker of skin irritation, inflammation
17. Effects of burn on inhalation injury
18. The effect of leukocyte depletion on smoke inhalation injury in sheep
19. Administration of synthetic antiprotease reduces smoke-induced lung injury
20. Effects of manganese superoxide dismutase on lung fluid balance after smoke inhalation
21. Pathophysiology of smoke inhalation
22. The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods
23. 2+-mediated oxidation of human low-density lipoproteins
24. Heparin protection against Fe2+- and Cu2+-mediated oxidation of liposome
25. The antioxidant activity of heparins
26. Dimethylsulfoxide with heparin in the treatment of smoke inhalation injury
27. Treatment of smoke-induced pulmonary injury with nebulized dimethylsulfoxide
28. The pathophysiology of inhalation injury - A review
29. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice
30. The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs
31. Lisofylline prevents leak, but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally
32. Modulating phosphatidic acid metabolism decreases oxidative injury in rat lungs
33. Antioxidant status of bronchoalveolar lavage fluid and lungs from rats subjected to burn and/or smoke inhalation
34. Lung and systemic oxidant and antioxidant activity after graded smoke exposure in the rat
35. Drowning and near-drowning
36. A dose-response model of smoke inhalation injury. Severity-related alterations in cardiopulmonary function
37. Effects of allopurinol on smoke inhalation in the ovine model
38. Lisofylline